Journal of psychopharmacology (Oxford, England)
June 1, 2026
Gabrielle Smith, Timothy Piatkowski, Jason Ferris et al.
1 citation
While research on novel therapeutic applications of ketamine is expanding, particularly in controlled settings, there is limited exploration of its consumption related to self-treatment of psychiatric conditions. This study investigated the characteristics of people who use ketamine and psychedelics for self-treatment of psychiatric conditions, providing insight into patterns of use within this...
Journal of sex research
January 16, 2026
Mason Levey, Benjamin Bonenti, Timothy Piatkowski et al.
Psychedelics are theorized to enhance emotional openness and interpersonal attunement, but their effects in sexual contexts - particularly among those with a history of sexual trauma - remain underexplored. This study investigated whether individuals who had used psychedelics to cope with or overcome sexual trauma (Psy-CST) reported different experiences of sexual communication and emotional...
Journal of psychopharmacology (Oxford, England)
2025
Karen P Barrios, Dean J Connolly, Jason Ferris et al.
17 citations
Ketamine's popularity has surged globally in the past decade, especially among young men. Emergency department visits due to its toxicity remain relatively rare, often linked to co-occurring use of other substances. Using data from the Global Drug Survey (GDS) 2018, this study explored the correlates associated with lifetime and past-year ketamine use, and estimated the socio-demographic...
Drug and Alcohol Review
November 5, 2024
Jordan J. Negrine, Cheneal Puljević, Jason Ferris et al.
8 citations
Abstract Introduction This study explores the attitudes of psychologists towards psychedelics and psychedelic‐assisted therapy (PAT) following the world‐first regulatory changes in 2023 in Australia which permitted psilocybin and 3,4‐methylenedioxy‐methamphetamine (MDMA) to be used in clinical services. Methods A purposive sample of 20 Australian psychologists was recruited using snowball...
Journal of psychopharmacology (Oxford, England)
August 1, 2024
Luke Baxter, Cheneal Puljević, Tim Piatkowski et al.
3 citations
The recreational use of LSD, a synthetic psychedelic drug, has surged in recent years, coinciding with a renewed research focus on its potential psychotherapeutic properties. This study aims to describe the experiences and perceptions of individuals engaging in LSD use for the first time, derived from a large international sample. This study utilised 2018 Global Drug Survey data collected from...
J Psychopharmacol
July 29, 2024
Claire Walker, Timothy Piatkowski, Jason Ferris et al.
4 citations
INTRODUCTION: This study explores how individuals self-treat psychiatric conditions with psychedelics outside medical guidance bridging the gap in understanding unregulated therapeutic use. AIMS: The primary objective was to extract specific factors underlying the effects of psychedelics, exploring their relationship with the need for medication, particularly for mental health conditions like...
Journal of Psychedelic Studies
August 19, 2023
Liam Engel, Monica J Barratt, Jason Ferris et al.
7 citations
Abstract Background and Aims Both Peyote and San Pedro cacti contain mescaline, a classical psychedelic eliciting mystical and visual effects, but only Peyote is a vulnerable species. We sought to address the questions 1; do people who use Peyote substitute with San Pedro, and vice versa, and; 2. how popular is the use of wild harvested mescaline cactus compared with the use of cultivated...